| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.004 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.092 | 0.004 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.091 | 0.006 |